Characteristic | Vascularisation | P | |
---|---|---|---|
 | Low | High |  |
Age in years | Â | Â | Â |
<50 | 4 (40%) | 6 (60%) | 0.97 |
50–64 | 12 (36%) | 21 (64%) |  |
>65 | 9 (36%) | 16 (64%) | Â |
Lymph node status | Â | Â | Â |
Negative | 16 (44%) | 20 (56%) | 0.26 |
Positive | 10 (31%) | 22 (69%) | Â |
Grade | Â | Â | Â |
I | 10 (37%) | 17 (63%) | 0.79 |
II | 9 (33%) | 18 (67%) | Â |
III | 6 (43%) | 8 (57%) | Â |
Oestrogen receptor | Â | Â | Â |
Negative | 17 (34%) | 33 (66%) | 0.43 |
Positive | 8 (44%) | 10 (56%) | Â |
Micrometastases (CK-19 RGE) | Â | Â | Â |
≥ 0.77 | 10 (30%) | 23 (70%) | 0.04 |
<0.77 | 15 (52%) | 14 (48%) | Â |
T-stage | Â | Â | Â |
T1/T2 | 21 (47%) | 24 (53%) | 0.05 |
T3/T4 | 5 (22%) | 18 (78%) | Â |